Announcement
Super Grannies and Market Update – June 30 Webinar Cancelled

If EPS Rises to Pre-Covid-19 Level, XLNX Could See Old Highs

- XLNX stock recovery from March lagging tech and cyclical stocks; we think unjustified

- Huawei, slowing 5G rollout fear has dented sentiment; in our Granny Shots portfolio

The image in this report is only accessible to members
- As sales approach pre-COVID-19 levels, stock could rise to old high, up to 40% riseXilinx (XLNX), which designs and develops programmable chips, has seen its share price rise about 50% to around $103 in the recent rally from the March lows, as the market broadly discounts a lessening of the COVID-19 spread, and a reopening o...

Finish reading this report for free

Enter your email and we’ll send the paywall-free report directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in
Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In

Events

Featured Research

Washed Out Stocks

Trending tickers in our research